Wieckowski K, Szalaj N, Gryzlo B, Wichur T, Goral I, Slugocka E, Sniecikowska J, Latacz G, Siwek A, Godyn J, Bucki A, Kolaczkowski M, Wieckowska A (2022) <br />Serotonin 5-HT(6) Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity-Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer's Disease<br /><i>Int J Mol Sci</i> <b>23</b>: <br /><br />Sari S, Barut B, Marcinkowska M, Sabuncuoglu S, Avci A, Kocak Aslan E, Ozel A, Siwek A (2021) <br />Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations<br /><i>Drug Dev Res</i> <br /><br />Wichur T, Pasieka A, Godyn J, Panek D, Goral I, Latacz G, Honkisz-Orzechowska E, Bucki A, Siwek A, Gluch-Lutwin M, Knez D, Brazzolotto X, Gobec S, Kolaczkowski M, Sabate R, Malawska B, Wieckowska A (2021) <br />Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT(6) receptor with anti-aggregation properties against amyloid-beta and tau<br /><i>Eur Journal of Medicinal Chemistry</i> <b>225</b>: 113783<br /><br />Wichur T, Godyn J, Goral I, Latacz G, Bucki A, Siwek A, Gluch-Lutwin M, Mordyl B, Sniecikowska J, Walczak M, Knez D, Jukic M, Salat K, Gobec S, Kolaczkowski M, Malawska B, Brazzolotto X, Wieckowska A (2021) <br />Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with beta-amyloid anti-aggregation properties<br /><i>Eur Journal of Medicinal Chemistry</i> <b>225</b>: 113792<br /><br />Lazewska D, Bajda M, Kaleta M, Zareba P, Doroz-Plonka A, Siwek A, Alachkar A, Mogilski S, Saad A, Kuder K, Olejarz-Maciej A, Godyn J, Stary D, Sudol S, Wiecek M, Latacz G, Walczak M, Handzlik J, Sadek B, Malawska B, Kiec-Kononowicz K (2020) <br />Rational design of new multitarget histamine H(3) receptor ligands as potential candidates for treatment of Alzheimer's disease<br /><i>Eur Journal of Medicinal Chemistry</i> <b>207</b>: 112743<br /><br />Malek R, Arribas RL, Palomino-Antolin A, Totoson P, Demougeot C, Kobrlova T, Soukup O, Iriepa I, Moraleda I, Diez-Iriepa D, Godyn J, Panek D, Malawska B, Gluch-Lutwin M, Mordyl B, Siwek A, Chabchoub F, Marco-Contelles J, Kiec-Kononowicz K, Egea J, de los Rios C, Ismaili L (2019) <br />New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition<br /><i>Journal of Medicinal Chemistry</i> <b>62</b>: 11416<br /><br />Marcinkowska M, Bucki A, Panek D, Siwek A, Fajkis N, Bednarski M, Zygmunt M, Godyn J, Del Rio Valdivieso A, Kotanska M, Kolaczkowski M, Wieckowska A (2019) <br />Anti-Alzheimer's multitarget-directed ligands with serotonin 5-HT6 antagonist, butyrylcholinesterase inhibitory, and antioxidant activity<br /><i>Arch Pharm (Weinheim)</i> <br /><br />Wieckowska A, Wichur T, Godyn J, Bucki A, Marcinkowska M, Siwek A, Wieckowski K, Zareba P, Knez D, Gluch-Lutwin M, Kazek G, Latacz G, Mika K, Kolaczkowski M, Korabecny J, Soukup O, Benkova M, Kiec-Kononowicz K, Gobec S, Malawska B (2018) <br />Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease<br /><i>ACS Chem Neurosci</i> <b>9</b>: 1195<br /><br />Wieckowska A, Kolaczkowski M, Bucki A, Godyn J, Marcinkowska M, Wieckowski K, Zareba P, Siwek A, Kazek G, Gluch-Lutwin M, Mierzejewski P, Bienkowski P, Sienkiewicz-Jarosz H, Knez D, Wichur T, Gobec S, Malawska B (2016) <br />Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation<br /><i>Eur Journal of Medicinal Chemistry</i> <b>124</b>: 63<br /><br />